(Q43673195)

25 November 2017

title

Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial (English)

1 reference

25 November 2017

Andreas Suter

1

1 reference

25 November 2017

Reinhard Saller

series ordinal

2

1 reference

25 November 2017

Eugen Riedi

series ordinal

3

1 reference

25 November 2017

Michael Heinrich

series ordinal

4

1 reference

25 November 2017

language of work or name

1 reference

23 April 2012

1 reference

25 November 2017

published in

Phytotherapy Research

1 reference

25 November 2017

volume

27

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

218-226

1 reference

Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extract

25 November 2017

cites work

1 reference

Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life

21 January 2018

1 reference

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

21 January 2018

1 reference

Safety and efficacy of the simultaneous administration of udenafil and an alpha-blocker in men with erectile dysfunction concomitant with BPH/LUTS.

21 January 2018

1 reference

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis

21 January 2018

1 reference

Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice

21 January 2018

1 reference

5-alpha reductase inhibitors and erectile dysfunction: the connection

21 January 2018

1 reference

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

21 January 2018

1 reference

Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction

21 January 2018

1 reference

Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression.

21 January 2018

1 reference

Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation.

21 January 2018

1 reference

Comorbid LUTS and erectile dysfunction: optimizing their management

21 January 2018

1 reference

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

21 January 2018

1 reference

An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia

21 January 2018

1 reference

Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand

21 January 2018

1 reference

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

21 January 2018

1 reference

Update on AUA guideline on the management of benign prostatic hyperplasia

21 January 2018

1 reference

Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events

21 January 2018

1 reference

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction

21 January 2018

1 reference

A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate

21 January 2018

1 reference

Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systematic review

21 January 2018

1 reference

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study

21 January 2018

1 reference

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

21 January 2018

1 reference

Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications

21 January 2018

1 reference

Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function

21 January 2018

1 reference

Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.

21 January 2018

1 reference

Measurement of benign prostatic hyperplasia treatment effects on male sexual function

21 January 2018

1 reference

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

21 January 2018

1 reference

Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction

21 January 2018

1 reference

Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride

21 January 2018

1 reference

Uses of saw palmetto (Serenoa repens, Arecaceae) in Florida

21 January 2018

1 reference

Distribution of the Brief Male Sexual Inventory in community men

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PTR.4696

1 reference

25 November 2017

1 reference